Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity

Hydrazide derivatives of Ilomastat, carrying either aryl groups or distinct alkyl and arylsulfonyl moieties were synthesized and evaluated for their MMP inhibitory activity. Potent and selective MMP-9 inhibition (IC 50 = 3 nM) was observed for compound 3m (arylsulfonyl group: 4-(4-Br–C 6H 4)–C 6H 4–...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2008-09, Vol.16 (18), p.8745-8759
Hauptverfasser: LeDour, Gwennaël, Moroy, Gautier, Rouffet, Matthieu, Bourguet, Erika, Guillaume, Dominique, Decarme, Martine, ElMourabit, Haquima, Augé, Franck, Alix, Alain J.P., Laronze, Jean-Yves, Bellon, Georges, Hornebeck, William, Sapi, Janos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hydrazide derivatives of Ilomastat, carrying either aryl groups or distinct alkyl and arylsulfonyl moieties were synthesized and evaluated for their MMP inhibitory activity. Potent and selective MMP-9 inhibition (IC 50 = 3 nM) was observed for compound 3m (arylsulfonyl group: 4-(4-Br–C 6H 4)–C 6H 4–SO 2–). Interaction with the S 2 enzyme subsite is mainly responsible for the inhibitory properties of this derivative as confirmed by molecular docking computation.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2008.07.041